Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deva Holding ASIST:DEVA +1.27%63 Days Payable is 58.87 as of Mar. 2026, which is 17% above its 10-year median of 50.40. GuruFocus rates IST:DEVA with a GF Score™ of 63/100 and a GF Value™ of ₺81.58 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 927 Drug Manufacturers companies, Deva Holding AS ranks worse than 76.05% on this metric.
The historical rank and industry rank for Deva Holding AS's Days Payable or its related term are showing as below:
IST:DEVA'
s Days Payable Range Over the Past 10 Years
Min: 41.46 Med: 50.4 Max: 97.47
Current: 48.24
During the past 13 years, Deva Holding AS's highest Days Payable was 97.47. The lowest was 41.46. And the median was 50.40.
IST:DEVA's Days Payable is ranked worse than 76.05% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs IST:DEVA: 48.24
Deva Holding AS's Days Payable
increased
from Mar. 2025 (34.63) to Mar. 2026 (58.87).
It may suggest that Deva Holding ASdelayed paying its suppliers.
Deva Holding AS Days Payable Related Terms
Deva Holding AS Days Payable Historical Data
* Premium members only.
The historical data trend for Deva Holding AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:DEVA vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deva Holding AS Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Deva Holding AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Deva Holding AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deva Holding AS (IST:DEVA) has a Days Payable of 58.87 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Deva Holding AS and its competitors. This is 17% above median its historical median of 50.40. Over the past decade, Deva Holding AS's Days Payable has ranged from 41.46 to 97.47. According to the industry distribution chart, Deva Holding AS ranks #705 out of 927 companies in the Drug Manufacturers industry, placing it in the top 76.1%.
Is Deva Holding AS's Days Payable too high?
Deva Holding AS's current Days Payable of 58.87 is 17% above median its 10-year median of 50.40. Over the past 10 years, this metric has ranged from a low of 41.46 to a high of 97.47. The Drug Manufacturers industry median Days Payable is 90.38. Deva Holding AS's value of 58.87 is 34.9% below this industry median. Based on the distribution chart, Deva Holding AS ranks #705 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Deva Holding AS has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deva Holding AS ranks #705 out of 927 companies for Days Payable. This places Deva Holding AS in the lower half of its industry. The industry median Days Payable is 90.38. Deva Holding AS's value of 58.87 is 34.9% below this benchmark. Historically, Deva Holding AS's own Days Payable has ranged from 41.46 to 97.47 over the past decade. While the company's 10-year median is 50.40 vs. the industry median of 90.38, Deva Holding AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deva Holding AS's current Days Payable of 58.87 is 34.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Deva Holding AS and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deva Holding AS's current Days Payable is 58.87, which is 17% above median its own 10-year median of 50.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺81.58, compared to a current price of ₺71.55 — trading 12.3% below its estimated fair value. The current Days Payable is 58.87, which is 17% above median its 10-year median of 50.40 and 34.9% below the Drug Manufacturers industry median of 90.38. Deva Holding AS's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current Days Payable is 58.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued.
The current stock price of ₺71.55 is trading 12.3% below its estimated GF Value™ of ₺81.58.
GuruFocus considers Deva Holding AS to be Modestly Undervalued.
Key valuation signals for IST:DEVA:
Days Payable: 58.87 (17% above median its 10-year median of 50.40)
GF Value™: ₺81.58 vs. price of ₺71.55 (12.3% below fair value)
Industry Position: 34.9% below the Drug Manufacturers median (#705 of 927)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
63GF Score
Get the complete analysis for IST:DEVA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
